These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6481115)

  • 1. The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy.
    McClain CJ; Potter TJ; Kromhout JP; Zieve L
    J Clin Gastroenterol; 1984 Aug; 6(4):325-9. PubMed ID: 6481115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sorbitol on psychomotor function: its use in alcoholic cirrhosis.
    McClain CJ; Kromhout JP; Zieve L; Duane WC
    Arch Intern Med; 1981 Jun; 141(7):901-3. PubMed ID: 7235810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychomotor performance defects in cirrhotic patients without overt encephalopathy.
    Gilberstadt SJ; Gilberstadt H; Zieve L; Buegel B; Collier RO; McClain CJ
    Arch Intern Med; 1980 Apr; 140(4):519-21. PubMed ID: 7362383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lactulose fermentation and lactose absorption in Chilean patients with liver cirrhosis: importance for hepatic encephalopathy therapy].
    Chesta J; Antezana C; Alegría S
    Rev Med Chil; 1993 May; 121(5):489-93. PubMed ID: 8272627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
    Zeng Z; Li YY
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
    Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L
    Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral bacteriotherapy with Bifidobacterium bifidum and Lactobacillus acidophilus in cirrhotic patients].
    Colle R; Ceschia T
    Clin Ter; 1989 Dec; 131(6):397-402. PubMed ID: 2534368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lactulose in the treatment of chronic portosystemic encephalopathies].
    Seidlová V
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):201-7. PubMed ID: 4447986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 11. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.
    Prasad S; Dhiman RK; Duseja A; Chawla YK; Sharma A; Agarwal R
    Hepatology; 2007 Mar; 45(3):549-59. PubMed ID: 17326150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short term effect of lactulose therapy in patients with chronic renal failure.
    Miura M; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1989 Mar; 14(1):29-34. PubMed ID: 2699952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
    Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hepatic encephalopathy with lactulose].
    Veljkov N; Kulenović S; Borovac N; Rezaković D
    Med Arh; 1981; 35(5-6):267-9. PubMed ID: 7345270
    [No Abstract]   [Full Text] [Related]  

  • 16. Lactulose for hepatic encephalopathy.
    Med Lett Drugs Ther; 1976 Jan; 18(1):3-4. PubMed ID: 1105127
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of lactulose and neomycin on urea metabolism in cirrhotic subjects.
    Weber FL; Fresard KM; Lally BR
    Gastroenterology; 1982 Feb; 82(2):213-7. PubMed ID: 7054022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lactulose in the therapy of porto-systemic encephalopathy].
    Almici C; Inzoli MR; Poloni AE; Zambruni A
    Minerva Med; 1973 Dec; 64(87):4596-603. PubMed ID: 4774227
    [No Abstract]   [Full Text] [Related]  

  • 19. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594755
    [No Abstract]   [Full Text] [Related]  

  • 20. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.